Testicular cancer: An oncological success story

Clinical Cancer Research

Volumn 3, Issue 12 II, 1997, Pages 2630-2632

  Einhorn, Lawrence H ^a,b  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; VINBLASTINE;

ANOREXIA; CONFERENCE PAPER; DRUG APPROVAL; FOOD AND DRUG ADMINISTRATION; GERM CELL TUMOR; HUMAN; LUNG FIBROSIS; MALE; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; ONCOLOGY; OTOTOXICITY; OVARY CANCER; PRIORITY JOURNAL; TESTIS CANCER; VOMITING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CISPLATIN; ETOPOSIDE; HUMANS; MALE; TESTICULAR NEOPLASMS; VINBLASTINE;

EID: 0031408767     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Einhorn, L. H. Testicular cancer: a model for a curable neoplasm. Cancer Res., 41: 3275-3280, 1981.
2. Einhorn, L. H. Treatment of testicular cancer: a new and improved model. J. Clin. Oncol., 8: 1777-1781, 1990.
3. Whitmore, W. F. Surgical treatment of adult germinal testis tumors. Semin. Oncol., 6: 55-68, 1979.
4. Donohue, J. P., Zachart, J. M., and Maynard, B. R. Distribution of nodal metastases in non-seminomatous testis cancer. J. Urol., 128: 315-320, 1982.
5. Li, M. C., Whitmore, W. F., Golbey, R., and Grabstald, H. Effects of combined drug therapy on metastatic cancer of the testis. J. Am. Med. Assoc., 174: 145-153, 1960.
6. Samuels, M. L., Lanzotti, V. J., Holoye, P. Y., Boylle, L. E., Smith, T. L., and Johnson, D. E. Combination chemotherapy in germinal cell tumors. Cancer Treat. Rev., 3: 185-204, 1976.
7. Rosenberg, B., VanCamp, L., and Krigas, T. Inhibition of cell division in E. coli by electrolysis products from a platinum electrode. Nature (Lond.), 205: 678-699, 1965.
8. Einhorn, L. H., and Donohue, J. P. Combination chemotherapy with cis-diamminedichloroplatinum, vinblastine, and bleomycin in disseminated testicular cancer. Ann. Int. Med., 87: 293-298, 1977.
9. Higby, D. J., Wallace, H. J., Albert, D. J., and Holland, J. F. Diamminedichloroplatinum: a Phase I study showing responses in testicular and other tumors. Cancer (Phila.), 33: 1219-1225, 1974.
10. Einhorn, L. H., Williams, S. D., Mandelbaum, I., and Donohue, J. P. Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction. Cancer (Phila.), 48: 904-908, 1981.
11. Einhorn, L. H., and Williams, S. D. Chemotherapy of disseminated testicular cancer. A randomized prospective study. Cancer (Phila.) 46: 1339-1344, 1980.
12. Stoter, G., Sleyfer, D. T., Bokkel Huinink, W. W., ten Kaye, S. B., Jones, W. G., van Oosterom, A. T., Vendrik, C. P. J., Spaander, P., de Pauw, M., and Sylvester, R. High dose versus low dose vinblastine in PVB: a randomized study of the EORTC. J. Clin. Oncol., 4: 1199-1206, 1986.
13. Einhorn, L. H., Williams, S. D., Troner, M., Greco, F. A., and Birch, R. The rise of maintenance therapy in disseminated testicular cancer: a Southeastern Cancer Study Group protocol. N. Engl. J. Med., 305: 717-731, 1981.
14. Bosl, G. J., Gluckman, R., Geller, N. L., Golbey, R. B., Whitmore, W. F., Herr, H., Sogani, P., Morse, M., Martini, N., Bains, M., and McCormack, P. VAB-6: an effective chemotherapy regimen for patients with germ cell tumors. J. Clin. Oncol., 4: 1493-1499, 1986.
15. Fitzharris, B. M., Kaye, S. B., Saverymuttu, S., Newlands, E. S., Barrett, A., Peckham, M. J., and McElwain, T. J. VP-16 as single agent in advanced testicular tumors. Eur. J. Cancer, 16: 1193-1197, 1980.
16. Schabel, F. M., Jr., Trader, M. W., Laster, W. R., Jr., Corbett, T. H., and Griswold, D. P. Cisplatin: combination chemotherapy and cross-resistance studies with tumors of mice. Cancer Treat. Rep., 63: 1459-1473, 1979.
17. Williams, S. D., Birch, R., Irwin, L., Greco, A., Loehrer, P. J., and Einhorn, L. H. Disseminated germ cell tumors: chemotherapy with cisplatin plus bleomycin plus either vinblastine or etoposide. N. Engl. J. Med., 316: 1435-1440, 1987.
18. Birch, R., Williams, S. D., Cone, A., Einhorn, L. H., Roark, P., Turner, S., and Greco, F. A. Prognostic factors for favorable outcome in disseminated germ cell tumors. J. Clin. Oncol., 4: 400-407, 1986.
19. Einhorn, L. H., Williams, S. D., Loehrer, P. J., Birth, R., Drasga, R., Omura, G., and Greco, F. A. Evaluation of optimal duration of chemotherapy in favorable prognosis disseminated germ cell tumors: an SECSG protocol. J. Clin. Oncol., 7: 387-391, 1989.
20. Loehrer, P. J., Johnson, D., Elson, P., Einhorn, L. H., and Trump, D. The importance of bleomycin in favorable prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial. J. Clin. Oncol., 13: 470-476, 1995.
21. Bajorin, D., Sarosdy, M. F., Pfister, D. .G., Mazumdar, M., Motzer, R. J., Scher, H. I., Geller, N. L., Fair, W. R., Herr, H., Sogani, P., Sheinfeld, J., Russo, P., Vlamis, V., Carey, R., Vogelzang, N. J., Crawford, E. D., and Bosl, G. J. Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors. J. Clin. Oncol., 11: 598-608, 1993.
22. Nichols, C. R., Williams, S. D., Loehrer, P. J., Greco, F. A., Crawford, D., Weetlaufer, J., Miller, M. E., Bartolucci, A., Schacter, L., and Einhorn, L. H. Randomized study of cisplatin dose intensity in advanced germ cell tumors: an SECSG and SWOG protocol. J. Clin. Oncol., 9: 1163-1172, 1991.
23. Nichols, C. R., Loehrer, P. J., Einhorn, L. H., Propert, K., Vogelzang, N. J., Crawford, E. D., Sarosdy, M., and Trump, D. Phase III study of BEP versus VIP in advanced stage germ cell tumors: an intergroup trial. Proc. Am. Soc. Clin. Oncol., 14: 239, 1995.
24. Einhorn, L. H., Weathers, T., Loehrer, P. J., and Nichols, C. Long-term follow-up of second-Line chemotherapy with vinblastine, ifosfamide, and cisplatin in disseminated germ cell tumors. Proc. Am. Soc. Clin. Oncol., 15: 240, 1991.
25. Broun, E. R., Nichols, C. R., Kneebone, P., Williams, S. D., Loehrer, P. J., Einhorn, L. H., and Tricot, G. J. K. Long-term follow-up of salvage chemotherapy in relapsed and refractory germ cell tumors using high dose carboplatin and etoposide with autologous bone marrow support. Ann. Intern. Med., 117: 124-128, 1992.
26. Broun, E. R., Nichols, C. R., Gize, G., Cornetta, K., Hromas, R. A., Schact, B., and Einhorn, L. H. Tandem high dose therapy with autologous bone marrow transplantation for initial relapse of germ cell cancer. Cancer, 79: 1605-1610, 1997.
27. Miller, K. D., Loehrer, P. J., Gonin, R., and Einhorn, L. H. Salvage chemotherapy with vinblastine, ifosfamide, and cisplatin in recurrent seminoma. J. Clin. Oncol., 15: 1427-1431, 1997.